Orticumab (Anti-oxLDL)
Product Specifications
CAS Number
1314241-10-5
Synonyms
MLDL1278A
Target
LDL
Applications
Metabolism
Additionnal Information
Orticumab (MLDL1278A) is an antibody targeting oxidized or malondialdehyde-modified lipoprotein (LDL) that specifically inhibits oxidised low-density lipoproteins (oxLDL) . Orticumab is involved in the modulation of autoimmune responses against oxLDL and improves atherosclerosis in an animal model. MW: 145.5 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682287-100 1x 100 µL
SOX9 / SRY-box 9 (SOX9/2287R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
13510-AAT 100 Tests
Amplite® Universal Fluorimetric MMP Activity Assay Kit *Green Fluorescence*
Sign In for Pricing
View Details 